1. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Norway (S.A., A.K.A., E.G., L.G.)
2. Center for Heart Failure Research, University of Oslo and Faculty of Medicine, University of Oslo, Norway (S.A.).
3. Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden (K.K., D.I.)
4. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (F.G.).
5. Department of Cardiology, Aarhus University Hospital, Denmark (H.E., H.E.B.).
6. The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Skåne University Hospital and Department of Clinical Sciences, Lund University, Sweden (G.R.).
7. Novartis Norge AS, Oslo, Norway (D.S.).
8. Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden (G.D.)
9. Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Norway (T.U., P.A.)
10. K.G. Jebsen Inflammatory Research Center, Faculty of Medicine, University of Oslo, Norway (T.U., P.A.).
11. K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Norway (T.U., P.A.)
12. Faculty of Medicine, University of Oslo, Norway (T.U., P.A., L.G.).
13. Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway (P.A.)